Rankings
▼
Calendar
SBFM Q4 2024 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena
SBFM
Sunshine Biopharma, Inc.
$6M
Q4 2024 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$10M
+24.9% YoY
Gross Profit
$3M
32.2% margin
Operating Income
-$2M
-21.2% margin
Net Income
-$2M
-22.5% margin
EPS (Diluted)
$-0.84
QoQ Revenue Growth
+13.8%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$4M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$31M
Total Liabilities
$7M
Stockholders' Equity
$24M
Cash & Equivalents
$10M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$10M
$8M
+24.9%
Gross Profit
$3M
$3M
+20.4%
Operating Income
-$2M
-$1M
-71.7%
Net Income
-$2M
-$1M
-72.6%
← FY 2024
All Quarters
Q1 2025 →